drugset / Trial / NCT01955980
Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The study should create data for the selection of a clinically relevant endpoint to assess the potential of Buparid/PARI SINUS to postpone sinus surgery in patients with chronic Rhinosinusitis.
Timeline
- Start
- 2015-10-27
- Primary completion
- 2018-09-27
- Completion
- 2021-07-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 50 ug | Inhaled |
| Comparator | Budesonide | Small molecule | 1 mg | Inhaled |